final score
DESCRIPTION
examination result. a ttendance and respond in class. experiment record. Final score. +. +. =. (100%) ( 80%) (10%) (10%). sign in and experiment record. sign in and respond in class. select question. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/1.jpg)
Final score
examination result
attendance and respond in class
experiment record = + +
sign in andrespond in class
select question sign in andexperiment record
(100%) ( 80%) (10%) (10%)
![Page 2: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/2.jpg)
(7 sections )
1. General Principles of Pharmacology (Yu
an)
2. Peripheral Nervous Pharmacology (Cao)
3. Central Nervous Pharmacology (Liu)
4. Cardiovascular Pharmacology (Zang)
5. Splanchnic and Blood Pharmacology (M
a)
6. Endocrine Pharmacology (Zhao)
7. Chemotherapeutic Pharmacology (Lin)
PharmacologyPharmacology
![Page 3: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/3.jpg)
PART 1 GENERAL PRINCIPLES OF
PHARMACOLOGY
Dr. Yuan Bing-Xiang Department of Pharmacolog
y, Medical School,
Xi’an Jiaotong University, Tel: 82657724,
Email: [email protected]
![Page 4: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/4.jpg)
1. Pharmacology can be defined as the science or course studying the interaction between drugs and bodies (living systems) including human being, animals and pathogens including pathogenic microorganisms (bacteria, virus, fungus…) , parasites and tumor cells…
Ⅰ CONCEPTION
CHAPTER 1 Introduction of Pharmacology
PharmacologyGENERAL PRINCIPLES
![Page 5: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/5.jpg)
Drugs are the chemicals beneficially altering biochemical and physiological states of body, applied to prevent, treat or diagnose diseases.
Pharmacology
DrugsAct onBodies
Peripheral Nervous Pharmacology Central Nervous Pharmacology Cardiovascular PharmacologySplanchnic Pharmacology Blood Pharmacology Endocrine Pharmacology
Systemsof bodies
Pathogens- Chemotherapeutic Pharmacology
Antibacterial drugs; Antifungal drugs; Antivirus drugs; AntiparasiticsAnticancer drugs
GENERAL PRINCIPLES
![Page 6: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/6.jpg)
Pharmacodynamics, PD
Pharmacokinetics, PK
Impact factors
2. Three aspects of pharmacology
drug body
PharmacologyGENERAL PRINCIPLES
![Page 7: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/7.jpg)
* therapeutic effects* adverse reaction
E
D
1) Pharmacodynamics (drug acts on body)
effects
action(mechanism of effect)
Drugs actions effects
* Specific actions: drug-receptors; drug-ion channels; drug-enzymes; * Unspecific actions: drugs influence physical and chemical condition around cells (pH, osmosis …)
Primary actingon the target
Secondary Inducing effects in the organ or system
PharmacologyGENERAL PRINCIPLES
* dose-effect curves └→PD parameters (KD, EMAX…)
![Page 8: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/8.jpg)
drug blood Concentration-Time curves
└→PD parameters from C-T curves: t1/2, Ka, Ke, F, Vd…
2) Pharmacokinetics (body acts on drug)
Undergoing of drug in body
absorption distribution excretion biotransformation
C-T curves
C
T
PharmacologyGENERAL PRINCIPLES
transportation
![Page 9: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/9.jpg)
GENERAL PRINCIPLES Pharmacology
3) Impact factors
drug
Drugphysico-chemical propertydosage formbatch number
Medicationdose and route
time and intervalcourse of treat
association
PK
PD
physiolo-patho-
psycho-geno-
living habit ……
body
DrugBody
![Page 10: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/10.jpg)
CHAPTER 2
pharmacokinetics
( body Acts on drug )
PHARMACOLOGIC PRINCIPLES
![Page 11: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/11.jpg)
(sites of action) binding free
(accumulation) free binding
drugs po sc im
(plasma)
Free drugs
binding drugs metabolites
(renal) excretion
Metabolism (liver)
absorption
distribution
distribution
distribution
pharmacokineticsUndergoing of drugs
transporttransformation
out of body
![Page 12: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/12.jpg)
The membranes with pore
are composed of lipids and
proteins in a ratio of 70:1.
The liquid-form double-deck
of membranes is formed
from lipid molecules; The
special proteins inserted into
the double-deck are
receptors, enzymes, ion
channels, carriers……
Ⅰ.Drug permeation across membranes1. Membrane
pharmacokinetics
O < >OO < >OO < >OO < >OO < >OO < >OO < >O
O < >OO < >O
O < >OO < >OO < >OO < >OO < >OO < >OO < >O
ATP
a Lipid diffusion
b Filtration
c Facilitated transport
d Active transport
eIon
transport
lipids
pore
carrier
ion channels
carrier
permeation across membranes
passive
![Page 13: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/13.jpg)
A drug molecule moves from a side of membrane relatively high concentration to another side of low concentration without requiring energy, until an equilibrium has been achieved on both sides of the membrane.
2. Passive transport across membranes(down hill)
high low
equilibrium
pharmacokinetics
Lipid diffusion; Filtration; Facilitated transport
permeation across membranes
…..…..…..…..…..
…..…..…..…..
…..…..…..
…..…..…
..
…..…..…
…..
…..…..
![Page 14: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/14.jpg)
Nonionized form Ionized form
1) Lipid diffusion ( Simple
diffusion)
ion trapping
←less polar molecules polar molecules→
The most important mechanism of drug transport
pharmacokinetics
pH (pKa) ┐ pKa is pH when Ionized rate is 50%
permeation across membranes
more lipid soluble less lipid soluble easy permeation hard permeation
Drug movement across membranes is driven by a concentration gradient after solution in the lipids of membranes.
k1
k2
![Page 15: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/15.jpg)
k1 [H+][A-] k1 [H+][B]
Ka =──=───── Ka =──= ──── k2 [HA] k2 [BH+]
[A] [B] pKa = pH - log ─── pKa = pH - log ─── [HA] [BH+]
[A-] [B] pH - pKa = log ─── pH - pKa = log ─── [HA] [BH+]
HA (weak acids) B (weak bases) k1 k1 HA H+ + A- B + H+ BH+
k2 k2
pharmacokineticsLipid diffusion
[A-] [B]─── = 10pH - pKa ─── = 10pH - pKa
[HA] [BH+]
![Page 16: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/16.jpg)
weak acids weak bases ★ pH↑↓→[A-]↑↓→ ★ pH↑↓→[BH+]↓↑→
Degree of ionization↑↓ degree of ionization↓↑
→lipid solution↓↑ →lipid solution↑↓
→permeation↓↑ →permeation↑↓
pharmacokinetics
[A-] [B] ─── = 10pH-pKa ─── = 10pH-pKa [HA] [BH+]
Lipid diffusion
Neither weak acids or weak bases are dissolved in same acid-base solution, the lipid solution↑, permeation↑; They are dissolved in opposite solution, the lipid solution↓, permeation↓.
![Page 17: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/17.jpg)
pharmacokineticsLipid diffusion
For example, Bicarbonate (NaHCO3)
is very effective for treatment of acute
toxication from weak acid drugs (like
barbiturates).
why ?
![Page 18: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/18.jpg)
① Alkalization of gastric juice →ionization↑
→ permeation↓ →absorption ↓
② Alkalization of blood plasma → permeation↓→across blood-brain barrier↓
gastric juice blood
drugdrug
blood Cerebrospinal fluid
drug drug
pH ↑ > pH[A-]↑ > [A-]
pH↑> pH[A-]↑> [A-]
Gastrolavage of NaHCO3
Intravenous drop of NaHCO3
pharmacokineticsLipid diffusion
![Page 19: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/19.jpg)
③ Alkalization of humor (extra-cellular fluid) →ionization↑ →permeation↓
④ Alkalization of urine→ionization↑ →permeation↓→ drug tubular reabsorption↓→ excretion↑
drug drug
drug [A-]↑urine pH ↑
pH < pH↑ [A-] < [A-] ↑
blood
cell
pharmacokineticsLipid diffusion
![Page 20: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/20.jpg)
* Water-soluble drugs with low molecular weight (Inc. some polar molecules) can diffuse through the aqueous pores of membrane.
* A almost free drugs can be filtrated across large pores of capillaries from or to plasma. (like drug distribution, glomerular filtration and absorption following im or sc injection)
2) Filtration (Aqueous diffusion):
pharmacokinetics
Small molecules (<100-200 dalton) pass through aqueous pores without requiring energy driven by concentration gradient.
filtration
![Page 21: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/21.jpg)
The movement of a drug across the membrane could be facilitated by its special carrier and concentration gradient. In the carrier-mediated transport, the drug is released to another side of the membrane, and the carrier then returns to original side and state.
3) Facilitated transport (Carrier-mediated transport)
pharmacokineticsfacilitated transport
![Page 22: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/22.jpg)
a. saturable process;
b. special binding to the carrier
c. cannot move against a concentration
gradient without energy.
The properties of facilitated transport are as follows:
pharmacokineticsfacilitated transport
![Page 23: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/23.jpg)
2. Active transport (up hill)
A drug molecule moves from a side of membrane relatively low to one of high concentration with requiring energy and special carrier.
pharmacokinetics
a. saturable process
b. special binding to the carrier
c. transport against concentration gradient with consuming energy.
Active transport
![Page 24: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/24.jpg)
For example: penicillin and probenecid
After glomerular filtration, penicillin undergoes tubular secretion (an active transport), having a very short half-life (t1/2=
20~30 min); probenecid having the same active mechanism can competitively inhibit the tubular secretion of penicillin. The t1/2 & effects of penicillin are prolonged.
Glomerular filtration (passive)
penicillin tubular Secretion (active)
Blood→tubule
Excretion of penicillin
probenecid
competitively inhibit
Blood→tubule
pharmacokineticsActive transport
H2O absorption
Tubule high osmosis
![Page 25: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/25.jpg)
The transport of drugs from administration locale to bloodstream.
Ⅱ.Absorption
pharmacokineticsAbsorption
![Page 26: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/26.jpg)
1. The routes of absorption
1) im or sc
Absorption of drugs in solution through filtration from subcutaneous or intramuscular injection sites to blood is limited mainly by blood perfusion rate.
pharmacokinetics
im > sc (adrenalin), why?
a. blood perfusion rate (im > sc)
b. adrenalin ┌α↑→vesseel↑(subcutaniea) → perfusion↓ └β↑→vesseel↓(skeleton muscle) →perfusion ↑
Absorption
![Page 27: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/27.jpg)
2) po (per oral)
Drugs are absorbed in gastrointestinal tract through lipid diffusion. The absorption takes place mainly in the upper small intestine.
With oral administration of drugs, extensive gastrointestinal and hepatic metabolism may occur before the drugs are absorbed into systemic circulation and reach its site of action. This process is defined as the first-pass elimination.
pharmacokinetics
gastric mucosa small intestine mucosa
Absorption
What about weak acids?
![Page 28: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/28.jpg)
Nitroglycerin given sublingually bypasses liver and enters the superior vena cava and, in turn, perfuses the coronary circulation, therefore is immediately effective to relive patients with angina pectoris.
3) Sublingual or rectal administration
Absorption properties of the administration a. incomplete and irregular absorption;
b. without or less First-pass elimination.
pharmacokineticsAbsorption
For example
![Page 29: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/29.jpg)
F would be the extent and rate of drug absorption following extravascular administration (like orally). F could be the absolute rate of a drug, used for indicating the absorption amount (AUC) compared with that of intravenous administration, or relative rate of a pharmaceutical product, used for indicating the absorption amount (AUC) compared with that of standard preparation in the same administration (same route and dose).
2. Bioavailability (F)
pharmacokineticsAbsorption
![Page 30: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/30.jpg)
A (drug amounts in body)=───────────── ×100% D (administered dose)
AUC (area under extravascular curve)=────────────────── ×100% AUC (area under intravenous curve)
AUC (test pharmaceutics)=────────────── ×100% AUC (standard preparation)
test
TT
standardC
iv
po
pharmacokinetics
F (absolute)
F(absolute)
F (relative)
im
C
Absorption
![Page 31: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/31.jpg)
The transport of drugs from
bloodstream to various organs
and tissues, or to different p
hysical compartments of bod
y.
Ⅲ.Distribution
pharmacokineticspharmacokinetics
Distribution
![Page 32: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/32.jpg)
1. Compartments
According to perfusion rate of drugs to various organs and tissues, body can abstractly be divided into one, two or more parts (one compartment model, two compartments model, three…).
pharmacokineticsDistribution
![Page 33: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/33.jpg)
Drugs within the model are assumed to be
distributed just to the organs or tissues with high
blood flow and rapid uniform (brain, heart, liver,
kidneys, lungs, active muscle, …). The C-T curve
have one phase: elimination. The distribution is
too rapid to be found in the C-T curve..
。。
Distribution
T
1) One compartment model
Kadrug
Ke
![Page 34: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/34.jpg)
drug
Ke
Distribution
Co
Tt1/2 t1/2
C
1/21/4
Ke。。
KCdt
dC
KteCC 0
t303.2
KlogClogC 0
logC
T
logC0
![Page 35: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/35.jpg)
pharmacokineticsDistribution
2) Two compartments model
Drugs are not only distributed to the organs or
tissues with rich blood perfusion (central
compartment), but also to that with low blood flow
(peripheral compartment: fat, skin, bone, resting
muscle). The C-T curve have two phases:
a. The distribution rate is known as the alpha
half-life, t1/2α.
b. The elimination rate is known as the beta
half-life, t1/2β.
![Page 36: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/36.jpg)
Ka
Ke
K1
K2
T
β
α
C
Ct = CAe-kαt + CBe-kβt
。。
pharmacokineticsDistribution
α
β
distribution
elimination
peripheral central
![Page 37: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/37.jpg)
Vd is that drug in a plasma concentration should
be solved in apparent volume of body fluid includi
ng the general circulation and the tissues. Vd is u
sed for measuring distribution range, relating the
amount in the body (A) to the concentration of dru
g (C ) in blood.
total amount of drug in body, A(mg) F.D Vd(L) =──────────────────── =── concentration of drug in plasma, C(mg/L) C
2. Apparent volume of distribution (Vd)
pharmacokineticsDistribution
![Page 38: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/38.jpg)
1) Barrier: blood-brain barrier, placental barrier)
a. less ionized drug & small particle→permeable
b. inflammation→permeable
iodium thyroid
2) active transport→tissues concentration↑ active transport
3) regional blood flow
subcutaneous < intramuscular
3. Factors influencing distribution
pharmacokineticsDistribution
![Page 39: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/39.jpg)
free drug + plasma binding drug (active form) (inactive storage form) small particle of drug large particle of drug →rapid filtration → no filtration → rapid distribution → → no distribution → ┌ action ┌no action└elimination └no elimination (metabolism & excretion)
moving balance
4) Binding rate to plasma : binding ratio to plasma protein at the therapeutic dosage.
pharmacokineticsDistribution
![Page 40: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/40.jpg)
Characters of binding to plasma a. saturability
Dose↑→binding rate ↓→free drug ↑
Malnutritionliver function↓
Renal function↓
free drug↑
Plasma-albumin↓
binding rate↓
b. Unspecific competition
combinationcompetive
bindingbinding
rate↓ free drug↑
B 92% (8%) →90% (10%) →effect (toxicity) ↑┅ ┅ ┅ ┅ ┅
A 98% (2%) ┅ ┅ ┅ ┅ ┅→96% (4%) →effect (toxicity)↑↑→bleeding2%↓
warfarin
phenylbutazone
![Page 41: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/41.jpg)
Phase 1
oxidation reduction hydrolysis
drug activity↓
Phase 2conjugation
toxicity↓ binding rate↓ more polar excretion↑
Inactivation
Prodrugs activation
Ⅳ.Biotransformationmainly in the liver
hepatic microsomal mixed function oxidase system
pharmacokineticsBiotransformation
with glycuronic acid
1. two phases
![Page 42: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/42.jpg)
2. Factors affecting drug metabolism
1) drugs
enzyme inducer
Chlorpromazine phenobarbital
activity of enzyme↑
→tolerance (dosage↑)
enzyme inhibiter
phenylbutazone chloromycetin
activity of enzyme↓
→hypersensitivity (dosage↓)
pharmacokineticsBiotransformation
![Page 43: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/43.jpg)
For example:
* Deficiency in the activity of acetylase results peripheral neuritis from isoniazid;
* Absence of glucose 6-phosphate dehydrogenase (G6PD) results hemolytic anemia from:
2) Pharmacogeneticshereditary variation in handling of drugs
pharmacokineticsBiotransformation
sulfonamides vitamin K (antihemorrhagic)primaquine (antimalarial agent) phenacetin (antipyretic analgesic) broad beans.
![Page 44: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/44.jpg)
Glucose
G-6-P
ATP
ADP
6-PG Acid
G6PD↓NADP
NADPH↓
GSSG
GSH↓
H2O2 ↑↑
H2O↓
Hemolytic anemia
Oxidizing agent
Absence of G6PD
sulfonamides vitamin K primaquine anminopyrine broad beans
+
Biotransformation pharmacokinetics
![Page 45: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/45.jpg)
3) Physiological and pathological condition
Age
elder
newborn
deficiency of drug elimination
toxicity of drugs
newborn
gray syndrome chloromycetin
numerous drugselder
toxicity↑
Less dosage
pharmacokineticsBiotransformation
liver functionrenal function
For example:
完善 flaw
Circulatory failure
![Page 46: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/46.jpg)
Illness
hepatic disease
enzymeproduction↓
hypersensitivity
Plasma production↓
drug metabolism↓
Plasma binding↓→free drug↑
Renal dysfunction
Plasma loss↑
Should dosage↓
pharmacokineticsBiotransformation
![Page 47: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/47.jpg)
Drugs and their metabolites in circu
lation are excreted by kidneys, bile, mi
lk, sweat and lungs.
Ⅴ.Excretion of drugs
pharmacokinetics
![Page 48: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/48.jpg)
glomerular filtration
tubular water reabsorption
Plasma (Drug & metabolites)
hyperosmotic in renal tubules
tubular reabsorption
lipid-solubility
tubular secretion
active diffusion
Drug excretion ↓ Drug excretion ↑
1. Renal excretion tubular secretion tubular reabsorption
Bicarbonate? Penicillin?
pharmacokineticsexcretion
Probenecid?
![Page 49: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/49.jpg)
Plasma(drug)
2. Excretion in bile
liver active transport
Hepato-enteric circulation
intestine
Excretion
portal vein
bile
prolongation of half-life high concentration in bile
Exclusion
pharmacokineticsexcretion
PO
Beneficial for antiinflammatory of cholecystitis
![Page 50: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/50.jpg)
3. Excretion in milk
weak alkaline drugs (morphine,
atropine)
nursing mother
lactiferous Ducts milk (low pH)
reabsorption concentrations in breast milk↑
effects↑
reactions in infant
fat-soluble drugs(sodium pentothal)
dissolved in the milk↑
pharmacokineticsexcretion
If the mather is the addict, whai would be resulted?
![Page 51: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/51.jpg)
pharmacokinetics
Ⅴ.Kinetics and rate process
Differental equation
Kinetics model
KCdt
dC
CPP
PCCC
CKCKdt
dC
CKCKKCdt
dC
1221
2112
Kinetics
K
drug
1 compartmentK12
K 21
Kdrug
2 compartment
![Page 52: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/52.jpg)
pharmacokinetics
1 compartment
Exponentequation
KteCC 0
tt BeAeC
Linear equation
t2.303
-logA)Be-log(C t 303.2
KlogClogC .-
0
t
t303.2
logBlogC
Semi-logarithmicequation
Kinetics
2 compartments
α
T
C
T
C
β
A
B
α
T
logC
T
logC
β
![Page 53: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/53.jpg)
1. Elimination of drugs
pharmacokineticsElimination
0 1 2 3 4 5 …… 9 10 11 12
1st-order 100 50 25 12.5 6.25 3.125
0-order 1000 900 800 700 600 500 …… 100 50 25 12.5
Drugs and their metabolites are eliminated from the body by excretion and metabolism with decrease of drug blood concentration.
![Page 54: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/54.jpg)
Blood concentration of drug is reduced in equal rate or in constant half-life (t1/2). The eliminated rate is direct ratio with blood concentration of a drug.
1KCdt
dC
1) First-order kinetic
t1/2
C
T
one compartment
pharmacokineticsElimination
All most drugs
KCdt
dC
![Page 55: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/55.jpg)
2) Zero-order kinetic
Blood concentration of drug is reduced in equal amount or eliminated in continuant shorten half-life (t1/2).
C
T
0K 0
dCC
dt
0
dCK
dt
![Page 56: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/56.jpg)
3) non-linear kinetics Low dose→ 1st order Overdose→ zero order
T
zero
T
Cfirst
aspirin
Low dose
1st order kinetics T1/2=2-3 h
Large dose Urine pH↓→reabsorption↑
zero order kinetics
T1/2=15-30 hC
salicylic acid, phenytoin, alcohol
![Page 57: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/57.jpg)
The half-life (t1/2) is the time required to decrease the
drug plasma concentration by one-half (50%) during elimination. It is considered that drugs are almost (97%) eliminated after 5 t1/2.
T1/2 is relates to drug character (lipid-solubility, size of
particle, molecular structure, drug interaction) and body condition (function of kidneys and liver…), but generally not relates to drug blood concentration and the routes of administration (therapeutic dose).
4) Half-life of drug (t1/2)
pharmacokineticsElimination
![Page 58: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/58.jpg)
pharmacokineticsElimination
C
TT1/2
C
TT1/2 T1/2
iv
po
t1/2
constant of a drug
Relation todrug character
lipid-solubility, size of particle, molecular structuredrug interaction
Individual variation
No relation to concentration of drug (therapeutic dose)way of administration
Relation tobody condition
KidneysLiver……
![Page 59: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/59.jpg)
When given at a regular interval, a drug plasma conc
entration approximately could reach a plateau after 5 t1/
2.
1) Level of Css relates to:
* dose ↑→Css↑
* interval shorten → wave of Css ↓
intravenous drip → smooth concentration curves.
( the most effective and safe administration)
2. Steady state concentration (Css)
pharmacokineticsSteady state
![Page 60: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/60.jpg)
* When a drug is given at a regular interval, its Css c
ould reached after 5 t1/2;
* loading dose →reaching Css rapidly
When the regular interval is t1/2 and loading dose is d
ouble , Css can be reached immediately in intravenous
injection.
2) Time to reach Css relates to:
pharmacokineticsSteady state
![Page 61: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/61.jpg)
0-order1st-order
C
T
pharmacokineticsSteady state
2D-D D
50%75%
87.5%
93.8%97%
ivd
C
T
![Page 62: Final score](https://reader035.vdocuments.net/reader035/viewer/2022062422/568134e7550346895d9c1e3e/html5/thumbnails/62.jpg)
T1/2 0 1 2 3 4 5… n
first -order
A. dose 100 100 100 100 100 100
amount 50 75 87.5 93.5 96.9… 100
B. dose 200 200 200 200 200 200
amount 100 150 175 187.5 193.8… 200
C. dose 200 100 100 100 100 100
amount 100 100 100 100 100
zero -order
dose 100 100 100 100 100 100…
amount 50 100 150 200 250…
Steady state concentration
pharmacokineticsSteady state